Matthew Draxton will share his story on NewsChannel 21 at Five
BEND, Ore. (KTVZ) — Three days after receiving an under-the-skin pain blocker injection for Osteoarthritis, a Bend dog passed away. The owner, Kyle Blankenship, says after the drug was administered to his dog, Sasha, she experienced paralysis and ultimately passed away. Blankenship has said he hopes to raise awareness about the drug and advises dog owners to do their research before agreeing to drug administering.
Librela (bedinvetmab) is a newer pharmaceutical drug in the veterinarian world, having been approved in the US, according to the American Veterinary Medical Association, in May 2023. According to the American Kennel Club, a not-for-profit organization since 1884, side effects from the drug Librela include a skin reaction at the injection site, urinary tract infections, and bacterial skin infections.
Currently there is a petition advocating for additional testing on the drug. The petition has garnered over 7,000 signatures since February.
Matthew Draxton is speaking with Blakenship about what the events leading up to his dogs passing and how he hopes to spread awareness. He is also reaching out to Bend vet clinics to talk with a doctor about the drug, the potential side effects, the factors to determine if a pet should be on the drug. He is also reaching out to the company behind Librela, Zoeta to see if they could talk about the drug more in-depth.
His report will be on NewsChannel 21 at Five.
This post was originally published on this site be sure to check out more of their content.
